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Abstract 
The water-soluble antioxidant, 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic (Trolox), (4-14C)-labelled, was used to trace its 
location in the aqueous and lipid phases of liposomes. Trolox was found to partition 20 to 25% into the lipid phase of multilamellar 
(MLV) and 38-46% into the lipid phase of unilamellar (ULV) egg lecithin liposomes. Trolox and its oxidation products partition readily 
(40%) into the lipid phase of dilinoleoylphosphatidylcholine (DLPC) MLV liposomes during inhibited peroxidation, thermally initiated by 
azo-bis(2,4-dimethylvaleronitrile) (ADVN). The time-course of the consumption of Trolox during peroxidation of DLPC liposomes, 
initiated by ADVN, was followed by separation and analyses of [4-~4C]Trolox and its oxidation products. Such studies showed that the 
consumption of Trolox followed the profile of the inhibition of oxygen uptake. This indicates that Trolox can be used in quantitative 
studies of membrane peroxidation; for example, to measure the rate of chain initiation (Ri). The product distribution of hydroperoxides, 
the 9- and 13-cis, trans (c,t) and trans, trans (t,t) isomers, formed uring inhibited peroxidation of linoleate, in DLPC and methyl linoleate 
in dimyristoyl PC (DMPC) liposomes was determined by HPLC of the derived hydroxy methyl esters. The c,t/t,t (kinetic/thermody- 
namic) ratios were related to the antioxidant activity of the inhibitors. Both Trolox and a-tocopherol (vitamin E) gave relatively high 
initial c,t/t,t ratios (6.6 and 7.1) during inhibited peroxidation of DLPC, initiated by water-soluble azo-bis(2-amidinopropane • HCI) 
(ABAP). High initial c,t/t,t ratios (6.2) were also observed for ce-tocopherol-inhibited peroxidation of DLPC liposomes, initiated by 
lipid-soluble ADVN. On the other hand, the combination of Trolox with ADVN-initiated peroxidation of DLPC or of methyl inoleate in 
DMPC gave relatively low initial c,t/t,t ratios of 3.5 and 1.3. These results are interpreted in terms of the relative hydrogen atom 
donating ability of the antioxidants and the homogeneity of the system used. The 9/13 ratios of hydroperoxides were constant (0.9 to 1.0) 
in all experiments and did not give evidence for preferential trapping by Trolox of peroxyls at the 9-position. 
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1. Introduction 
Nature provides a number of water-soluble antioxidants 
which inhibit membrane damage by acting as anti-per- 
oxidizing agents in trapping oxygen-centred radicals 
through a free radical chain-breaking mechanism, Consid- 
erable interest over the past decade has been devoted to 
such natural antioxidants as vitamin C [1-3], uric acid 
[4-6], and natural thiols [7-10]. Since its synthesis twenty 
years ago [11], the synthetic phenolic antioxidant, Trolox, 
has been examined for its antioxidant action by a number 
of investigators in a variety of systems. The structure of 
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Trolox (1) exhibits the requirements for effective antioxi- 
dant action; namely, it is a hindered phenol with a para  
ether oxygen in a ring system so that the structure pos- 
sesses the requirement for stereoelectronic stabilization 
[ 12] of the resulting phenoxyl radical, 2, on hydrogen atom 
transfer to an active oxygen radical, such as peroxyl 
(Scheme 1). 
Because of this chromanol structure, which provides the 
antioxidant activity and the carboxyl group which effects 
moderate water-solubility, Trolox has advantages over 
other active antioxidants (e.g., vitamin E) which are only 
lipid-soluble. For example, Trolox does not have to be 
incorporated into the lipid membrane by solvent extraction 
and coevaporation methods; it can be added directly to the 
intact system. This makes it convenient for studies on 
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natural biological systems and for quantitative studies on 
model systems. 
Trolox is known to exhibit antioxidant activity under a 
variety of conditions in various systems. It is an effective 
food preservator [13,14]. Trolox inhibits the radical chain 
oxidation of proteins [15-17] and enzymes [18-23], and 
prevents the loss of serotonin and dopamine receptor bind- 
ing sites in animal brain membranes [24,25]. There is 
evidence that Trolox also provides protection against free 
radical cell damage of various types, [26-30] especially 
when 'conjugated' to lactosylphenylpyranoside [31]. The 
peroxidation of cholesterol in dipalmitoylphosphatidyl- 
choline liposomes is inhibited effectively by Trolox, even 
when compared to the effect of vitamin E [32]. This 
suggests that Trolox may be effective against he peroxida- 
tion of low density lipoprotein. 
Preliminary studies showed that water-soluble initiators 
and water-soluble antioxidants (e.g., Trolox), as well as 
lipid soluble ones, can be used for quantitative kinetic 
measurements of peroxidation of model membranes [33]. 
Quantitative methods for obtaining antioxidant activities of 
phenols are based on the termination of peroxyl radicals by 
Eqs. (1) and (2). 
kinhibition 
ROO. +ArOH ~ ROOH+ArO.  (1) 
specifically how and where it operates its antioxidant 
activity in lipid membranes. Consequently, we now report 
on the following quantitative r sults from the behaviour of 
Trolox in phosphatidyl choline (PC) membranes. 
(1) The location of Trolox between the aqueous phase 
and lipid phase of multi-lamellar vesicles (MLV) and 
between these phases of unilamellar vesicles (ULV) of egg 
lecithin is determined by partitioning studies employing 
14C-4 radio-labelled Trolox. 
(2) The partitioning of [14C]Trolox, together with its 
products, between aqueous and membrane phases is deter- 
mined during the peroxidation of dilinoleoylphosphatidyl- 
choline (DLPC) under known and controlled conditions of 
the rate of free radical chain initiation. 
(3) A comparison is made between the conversion of 
Trolox to its oxidation products and the profile of the 
induction period (e.g., oxygen uptake) during Trolox-in- 
hibited peroxidation of DLPC liposomes. 
(4) Comparisons are made of the linoleate hydro- 
peroxide product distributions during Trolox-inhibited per- 
oxidation of DLPC iiposomes with those product distribu- 
tions during vitamin E-inhibited peroxidation, for peroxi- 
dations initiated by a water-soluble initiator azo-bis(2- 
amidinopropane. HCl) (ABAP) and by a lipid-soluble 
initiator azo-bis(2,4-dimethylvaleronitrile) (ADVN). 
fast 
ROO • + ArO • ~ non - radical products (2) 
Antioxidant activities are determined by measuring the 
reduced rate of oxygen uptake by a substrate in the pres- 
ence of known amounts of inhibitor during the inhibition 
period until the antioxidant is used up. These methods 
were used earlier to measure antioxidant activities of a 
variety of hindered phenols in membranes [34]. However, 
it was discovered recently that the effect (kin h) of a 
water-soluble antioxidant, including Trolox, to inhibit per- 
oxidation of phospholipid membranes depends markedly 
on the charge type of the membrane [35]. Negatively 
charged membranes, including dilinoleoylphosphatidyl- 
choline (DLPC) at pH 11, were found to undergo uninhib- 
ited peroxidation i  the presence of Trolox [35] which is 
reported to be as effective as a-tocopherol at pH 7 [34]. 
In view of the significance of a water-soluble antioxi- 
dant like Trolox in both physical organic and biochemical 
research on membranes, it is desirable to determine more 
2. Mater ia l s  and  procedures  
2.1. Mater ia ls  
The phospholipids, egg lecithin, DLPC and DMPC 
were purchased from Avanti Polar Lipids and stored at 
- 30 ° C. Methyl linoleate was obtained from Nuchek Prep. 
The azo initiators ADVN and ABAP were purchased from 
Polysciences. Trolox was purchased from Aldrich Chemi- 
cals and radioactive [4-14C]Trolox, specific activity of 57.5 
mCi/mg, was a gift from Hoffman-LaRoche. Trolox 
quinone was prepared by the oxidation of Trolox using a 
known procedure [13]. c~-Tocopherol was purchased from 
Aldrich Chemicals. Phosphate buffer was prepared from 
0.05 M each of NaH2PO 4 and Na2HPO 4 in deionized 
water containing 0.10 mM EDTA. The buffer was passed 
through a 50-100 mesh Chelex 100 column (Bio-Rad) to 
remove traces of heavy metal ions. 
T ~'r "COO'I 
1 1 
Scheme 1.
L.R.C. Barclay et aL / Biochimica et Biophysica Acta 1237 (1995) 77-85 79 
2.2. Liposome preparations 
The multilamellar vesicles (MLV) containing known 
amounts of additives, such as cz-tocopherol and ADVN 
(when required) were prepared by coevaporation from 
methanol, followed by vortex stirring and by freeze-thaw 
cycles in liquid nitrogen as reported before [34]. Unilamel- 
lar vesicles (ULV) were prepared by several passes of 
MLV through membranes in a pressure extruder as de- 
scribed earlier [32]. The nature of the MLV and ULV 
particles was checked by determining the 31P-NMR spectra 
of samples prepared by these procedures but using Tham 
buffer at pH 7. The 31P-NMR spectra measured on a JEOL 
270 MHz Spectrometer, using pulse sequences as reported 
[36], exhibited broad anisotropic signals for the MLV 
samples with chemical shift anisotropies of 45 ppm. The 
31p-NMR spectra of extruded samples exhibited single 
isotropic lines typical of ULV liposomes [32,36]. 
Another 50 /xl sample was taken directly from the cell in 
the bath and counted. This measurement was the Trolox 
dissolved in the water and the lipid. The lipid solubilized 
Trolox was calculated by subtracting the aqueous Trolox 
from the total Trolox in the sample. 
Partitioning of [ 14 C]Trolox during peroxidation of DLPC 
liposomes was carried out under oxygen in the autoxida- 
tion apparatus. A typical procedure used an initial sample 
of 3.00 ml of multilamellar DLPC (18.1 • 10 -3 mol) con- 
taining 3.80. 10 -6 mol of initiator (ADVN). In order to 
follow the oxygen uptake during the inhibition period and 
take samples throughout for analysis, a preferred procedure 
involves two identical runs - one is used to measure the 
uninterrupted oxygen uptake and, the other is used to take 
samples at convenient imes to separate and count the 
DPM in the aqueous and dispersion phases as above. 
2.5. Analyses 
2.3. Autoxidation / inhibition procedures 
The autoxidation kinetic and inhibition studies were 
carried out at 37°C under 760 torr of oxygen by oxygen 
uptake methods, using a calibrated dual channel high 
sensitivity pressure transducer system that was described 
in detail before [37]. The procedure used varied somewhat 
with the type of initiation and inhibition. When the water- 
soluble initiator/inhibitor combination (ABAP/Trolox) 
was used, a known amount of ABAP in phosphate buffer 
was added to the DLPC liposomes, equilibrated in the 
apparatus at 37 ° C, and when a constant rate of oxygen 
uptake was observed, a known amount of a solution of 
Trolox was added to give induction periods long enough 
(e.g., several hours) to take samples for HPLC analyses or 
for radiometric counting. When the lipid-soluble 
initiator/inhibitor combination (a-tocopherol/ADVN) 
was used, the previously frozen liposomes were equili- 
brated in the apparatus to 37 ° C. The error involved in 
measuring the induction period due to the 'lag time' in 
such experiments was described earlier [34]. 
2.4. Partitioning studies using [ 14 C]Trolox 
[J4C]Trolox was added to a 2.00 ml dispersion of 
multilamellar egg lecithin (10.7 mM) to make 0.01%, 
0.1%, 1% and 4% mol% Trolox samples. The samples 
were mixed at 250 rpm under nitrogen in a shaker bath set 
to 37 ° C. Samples of 200/xl were taken from each disper- 
sion after 45 min and 18 h of continuous haking and then 
placed inside an ultrafiltration cone (Cf 50A Amicon 
Centriflo). The cone was placed inside a centrifuge tube 
and centrifuged at 2000 × g for 15 min. A 50 /xl sample 
was then removed from the collecting tube and disintegra- 
tions per rain (DPM) counted, and these are converted to 
moles from the known amount of [laC]Trolox used. This 
measurement represents he Trolox dissolved in the water. 
In order to follow the consumption of Trolox during 
inhibition periods, preliminary experiments were per- 
formed to determine an optimum ratio of Trolox (2.60. 
l0 -8 mol) to initiator, ADVN (2.54. l0 -6 mol), in DLPC 
(8.50" 10 -3 mol) for an induction to last several hours. 
The experiment was then repeated using [ 14 C]Trolox. Sam- 
ples (30/zl) were removed after 0, 2, 4 and 7.5 h, and 5/xl 
of ordinary Trolox (2.80 mM) was added to each to 
prevent further oxidation during analysis. The samples 
were applied to the preadsorbant s rip of Whatman TLC 
plates (LKClsE) and the chromatogram developed by a 
mixture of benzene/ethyl acetate/acetic acid (89:9:2). 
The R F value for Trolox was 0.71. X-ray film (Kodak- 
XAR-5) was used to 'photograph' the location of the 
radioactive components on the TLC plates. The film was 
exposed to the plates for 24 h, then the TLC was sectioned 
based on the location of the radiolabels, the adsorbant 
scraped off and counted for the DPM. The amount of 
Trolox was calculated from the DPM for each sample. The 
DPM were counted in liquid scintillation vials on a LKB- 
Wallac Rackbeta 1211 scintillation counter. 
The products from peroxidation of linoleate in DLPC 
and methyl inoleate in DMPC liposomes were reduced to 
hydroxy derivatives by PhaP, and converted to methyl 
esters for HPLC analysis by known procedures [36]. The 
four regio-geometrical isomers were separated on a 4 × 250 
mm, 5 p, silica column (Jones Chromatography) using a 
mixture of hexane/2-propanol/acetone in ratios of 992:4:4 
volumes and a flow rate of l to 2 ml per min to achieve 
optimum separation. The isomers elute in the order: (1) 13 
cis, trans, (2) 13 trans, trans, (3) 9 cis, trans and (4) 9 
trans, trans. The peaks areas were corrected for the known 
molar absorptivities and the ratios calculated as before 
[36]. 
Mass spectroscopic analyses were carried out using a 
Hewlett-Packard 5988A Quadrupole mass spectrometer 
with the electron energy set at 70 eV. The direct insertion 
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probe was used to inject Trolox and Trolox quinone. 
Under these conditions, Trolox exhibited its parent mass 
(M ÷) at m/z  = 250 (100%) and significant fragment ions 
at m/z  = 205 (50% due to loss of HCO 2 and m/z  = 164 
(90%), loss of CH 2 = CCH3COOH, due to a two-bond 
scission fragmentation. The mass spectrum of the quinone 
was more complex. The parent mass was observed m/z  
= 266 (t9%). Significant fragment ions appeared in the 
higher mass range at m/z  = 220 (17%), loss of HCOOH 
in a cyclic elimination; and at m/z  = 203 (38%) for loss 
of water and of HCO 2. 
The Trolox quinone was also characterized by its ~3C- 
NMR spectrum. The chemical shifts and assignments are: 
12.1, 12.3, 12.5, 3-CH~ on the ring; 6 26.1, CH 3 at C-2 
chain; 6 21.1 and 38.0 CH 2 at C-3 and C-4; 6 74.5 C-2; 
140.5, 140.9, 141.1, 143.0 for alkene carbons in ring; ~5 
180 COOH; and 6 187.4, 187.5 for the two C~O groups. 
Trolox gave the expected 13C-NMR. 
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Fig. 2. Trolox (%) in water vs. mol% of Trolox in unilamellar egg 
lecithin. Respective ratios of Trolox were mixed with 2.13.10 -5 mol of 
egg lecithin in 2.00 ml of 10 mM phosphate-buffered saline. (• )  after 45 
min of shaking (cross-hatched) after 18 h of shaking. Error bars refer to 
standard errors of the mean (S.E.). 
3. Resu l ts  
3.1. The partitioning of Trolox between aqueous and lipid 
phases of egg lecithin liposomes 
Results of partitioning studies of Trolox between phos- 
phate buffer (pH 7) aqueous phase and egg lecithin lipid 
phase when different amounts of Trolox were shaken with 
multilamellar (MLV) liposomes for known times are out- 
lined in Bar plot profiles produced in Fig. 1. It is clear that 
the bulk of the Trolox remains in the aqueous phase; 
ranging from 80%, for 0.01 mol% Trolox introduced, to 
approx. 75% for 4 mol% Trolox used when the mixture is 
shaken for an extended time. 
Results for partitioning of Trolox under similar condi- 
tions as above, but employing unilamellar vesicles (ULV) 
100 
9o 
80 
~: ro 
.~. 60 
0 50 
0 
~.- 40 [,.. 
30 
20 
lo 
o 
0.01 0.1 1.0 4.0 
mole % of Trolox 
Fig. 1. Trolox (%) in water vs. mo1% of  Trolox in multilameUar lecithin, 
Respective ratios of Tro]ox were mixed with 2.]3. ]0 -5 mol of  egg 
lecithin in 2.00 ml of  ]0 mM phosphate-buffered saline. (• )  after 45 min 
of shaking (cross-hatched) after 18 h of shaking. 
of egg lecithin, are plotted as before in Fig. 2. The trend of 
partitioning into ULV is now quite different from that with 
MLV liposomes. Compared to the MLV egg lecithin, we 
now find that appreciably more Trolox becomes mem- 
brane-bound. With 4 tool% Trolox added initially, up to 
38-46% partitions into the lipid phase of ULV liposomes. 
These results for partitioning of Trolox into MLV and 
ULV are in general agreement with earlier data using other 
methods (e.g., spectroscopic) where up to 30% partitioning 
into egg lecithin ULV was found [35]. 
3.2. The partitioning of Trolox between aqueous and lipid 
phases of DLPC liposomes during controlled peroxidation 
It was of interest o determine the partitioning of Trolox 
and its oxidation products during the course of peroxida- 
tion of liposomes. For this experiment, he system selected 
was peroxidation of MLV liposomes of DLPC thermally 
initiated by the lipid-soluble initiator, azo-bis(2,4-dimeth- 
ylvaleronitrile) (ADVN). In this system the peroxidation is
controlled by a known and controlled rate of initiation (R~) 
since the R~ is controlled by the initiator, R~ = 
2kie[ADVN], where k i is the rate constant for initiator 
decomposition and e is its efficiency, both of which are 
known [35]. In addition, the free radical peroxidation 
products from the linoleate chain of DLPC can be deter- 
mined (vide infra). 
The partitioning of Trolox with its oxidation product(s) 
together with the profile of the resulting inhibition of 
azo-initiated peroxidation of MLV liposomes of DLPC are 
illustrated in Fig. 3. The proportion of Trolox and its 
products which are membrane-bound remains quite con- 
stant and at a higher value, approximately 40%, than that 
found for Trolox in MLV egg lecithin liposomes under 
argon, approx. 16% (Fig. 1). 
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Fig. 3. Trolox partitioning during inhibition run. Four samples were 
removed at 45, 96, 144 and 198 min after injection of 2.09. I0 -8 tool of 
Trolox in 14.2 mg, 1.82.10 -5 mol, /ml of DLPC in 3.00 ml of phos- 
phate-buffered saline (10 mM, pH 7.4). ADVN, 1.2- 10 -6 mol/ml. A, 
uninhibited reaction; B, inhibited reaction. 
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Fig. 4. Decay of Trolox during inhibition. Four samples were removed at 
0, 2, 4 and 7.5 h after injection of 2.60.10 -8 mol of Trolox (14C) to 2.00 
ml of multilamellar dilinoleoylphosphatidylcholine (8.50 mmol) with 
2.54.10 -6 mol ADVN. The total yield of Trolox was not determined. 
Mol of Trolox (T) and quinone (Q) shown are amounts determined in 
each sample taken. A, unhibited reaction; B, inhibited reaction. 
3.3. Comparison between the time-course of Trolox oxida- 
tion and the induction period during trolox-inhibited per- 
oxidation of DLPC liposomes 
In order for Trolox to be used for quantitative studies of 
peroxyl radical trapping in aqueous liposomes, the classi- 
cal Eqs. (1) and (2) for a phenolic inhibitor must apply so 
that each molecule of Trolox traps two peroxyl radicals. In 
addition, for quantitative studies in heterogeneous aqueous 
systems, it is necessary to determine if the Trolox is 
consumed by the end of the inhibition period of peroxida- 
tion in the lipid phase, although it is distributed between 
the two phases of water and lipid. If both of these condi- 
tions are met, the rate of free radical chain initiation (R i) 
is given by Eq. (3), 
R i = 2[inhibitor]/~- (3) 
where ~- is the length of the induction period during which 
oxygen uptake is suppressed. This relationship is very 
significant, because it is used to measure the rate of free 
radical chain initiation (R i) required for quantitative ki- 
netic studies [33]. 
We found recently that Trolox does indeed trap two 
peroxyls radicals per molecule of Trolox during inhibited 
peroxidation of DLPC iiposomes [35]. The present study 
was carried out to determine the consumption of Trolox 
during the course of the induction period. This study was 
carried out using [4-14C]Trolox as in the partitioning stud- 
ies, then separating by TLC the Trolox (R F = 0.71) from 
the membrane and Trolox oxidation products and quantita- 
tive determination, by the usual counting technique, of the 
amounts of Trolox and its products during the course of 
the inhibited peroxidation. A typical result of such a 
time-course profile is illustrated in Fig. 4. Such results 
show that Trolox decreases steadily and is essentially all 
consumed near the end of the induction period (where the 
lines cross from the slope of the induction period and 
where the oxygen uptake returns to the original rate), while 
the amount of the quinone increases. 
Our original [~4C]Trolox contained an unidentified 
component which developed more rapidly than Trolox or 
quinone, 3, on the TLC sheet (R F = 0.83). The aliquots 
from oxidation of DLPC containing [14C]Trolox also 
showed this component initially. This component decayed 
with time along with Trolox, both to form 3, and the sum 
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OH H H 
I I I CH C C 
65H11 / C '~ C'~ X(CI,.12)TCOOCH3 
f I 
H H 
Scheme 2. 
,. o. 
/C .  C,,,, ,,CH 
H C C \(CI"Fz)TCOOCH3 
r I 
H H 
H H (CH2)7COOCH3 
I I 
C ,,C~ ,CH 
CsHll / "~C '~C OH 
I 1 
H H 
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of the counts of this component and Trolox during the run 
was the same as the quinone formed. The final oxidation 
product of Trolox in water is known to be the quinone and 
intermediate oxidation products of Trolox also form the 
quinone in water [38,39]. The adduct from the Trolox 
radical, 2, with peroxyls is expected to hydrolyze rapidly 
to the quinone, as observed for such adducts with vitamin 
E [40]. These two sources of the quinone, the adduct with 
peroxyls and intermediates initially present, would account 
for the increase yield of 3 compared to the original Trolox 
(Fig. 4). This does not alter the essential result; namely, 
that Trolox is consumed by the end of the induction period 
in our experiments. 
3.4. Product studies of linoleate hydroperoxides during 
inhibited peroxidation(s) 
The products of free radical peroxidation of linoleate 
are the known 9- and 13-hydroperoxy-substituted 9- 
cis, ll-trans; lO-trans,12-cis; 9-trans,11-trans; and 10- 
trans,12-trans octadecadienoates, which are characterized 
by reduction and conversion to the corresponding hydroxy- 
methyl esters (4, 5, 6, 7 shown in Scheme 2), and the latter 
are separated and quantified by known HPLC methods 
[41,421. 
These product studies were carried out during inhibited 
peroxidations of DLPC in MLV liposomes under a variety 
of conditions. Hydroperoxides were analyzed when peroxi- 
dations were initiated by the water-soluble initiator, azo- 
bis(2-amidinopropane. HC1, ABAP) and inhibited by 
lipid-soluble a-tocopherol (vitamin E) or by water-soluble 
Trolox. Similarly, product studies were performed for reac- 
tions initiated by the lipid-soluble initiator, azo-bis(2,4-di- 
methylvaleronitrile) (ADVN) during inhibition by a- 
tocopherol or by Trolox. 
Product analyses for the combination oz-tocopherol and 
ABAP are given as a time-course study of the ratio of 
cis/trans to trans/trans (c,t/t,t) products, as well as 
that of the ratios of substitution at the 9/13 positions as 
illustrated in Fig. 5. The extrapolated value of the c,t/t,t = 
6.6 is attributed to the good hydrogen atom donating 
ability of vitamin E which traps the c,t or kinetic products 
before extensive isomerization to the more stable (thermo- 
dynamic) t,t isomers. This is in general agreement with 
earlier observations when higher c,t/t,t ratios were found 
for much higher vitamin E contents [42]. 
Results from product analyses using the combination of 
Trolox with initiation of peroxidation of DLPC by ABAP 
are illustrated in Fig. 6. The extrapolated c,t/t,t ratio to 
zero time = 7.1 is similar to that found for vitamin E. 
However, the slope of the time profile with Trolox is more 
shallow, -0 .16 versus -0.58 with vitamin E, with a 
sudden drop of the c,t/t,t ratio immediately following the 
end of the inhibition period. These results indicate that 
Trolox is a better inhibitor than vitamin E under these 
conditions. This was found to be the case during Trolox or 
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Fig. 5. Cis, trans to trans, trans (c,t/t,t) linoleate hydroperoxides (0 )  and 
9/13 ratios ( * ) ,  from peroxidation of DLPC, initiated by ABAP and 
inhibited by vitamin E, by HPLC analysis of the hydroxymethyl esters. 
The end of the induction period is shown by $. The rate of chain 
initiation, R i = 2[inhibitor]/7, measured by Trolox = 10.1.10 -s  M s - i .  
Molar quantities are oz-tocopherol, 4.94.10 -8 mol; DLPC, 3.20.10 -5 
mol; ABAP, 2.69- 10 -6 tool. 
vitamin E inhibited, and ABAP-initiated peroxidation of 
linoleic acid in SDS using oxygen uptake studies [43] but 
more recently Trolox was reported to have 60-72% of the 
antioxidant efficiency of vitamin E in this medium using a 
spectral analysis of diene formation from linoleic acid [44]. 
Next we compare the effect of vitamin E with Troiox 
on the c,t/t,t ratios during the inhibition period when 
peroxidation of DLPC liposomes is initiated in the lipid 
phase by the lipid-soluble initiator, ADVN. Typical results 
of these c,t/t,t analyses are given in Fig. 7 for vitamin 
E-inhibited peroxidation and Fig. 8 for Trolox-inhibited 
peroxidation. The results for the vitamin E inhibited, 
ADVN initiated peroxidation are remarkably similar to 
those during the ABAP initiated reaction (Fig. 5) both in 
the extrapolated c,t/t,t ratios, 6.2 when using ADVN and 
6.6 when using ABAP, and in the slopes of the two plots. 
Significant differences result for the ADVN-initiated, 
Trolox-inhibited experiments compared with those inhib- 
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Fig. 6. Cis, trans to trans, trans (c,t/t,t) linoleate hydroperoxides (0 )  and 
9/13 ratios (• ) ,  from peroxidation of DLPC, initiated by ABAP and 
inhibited by Trolox. The end of the induction period is shown by $. The 
rate of chain initiation, R~ =9.63-10 -8 M s - I .  Molar quantities are 
Trolox, 3.56.10 -8 mol, DLPC, 3.20.10 -5 mol; ABAP, 2.70.10 -6 tool. 
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Fig. 7. Cis, trans to trans, trans (c,t/t,t) linoleate hydroperoxides (O) and 
9/13 ratios (v ) ,  from peroxidation of DLPC, initiated by ADVN and 
inhibited by vitamin E. The end of the induction period is shown by ,l.. 
The rate of chain initiation, measured using Trolox = 7.45.10 -8 M s -] . 
Molar quantities are a-tocopherol, 3.33.10 -8 mol; DLPC, 3.10.10 -5 
mol; ADVN, 3.25.10 -6 mol. 
ited by vitamin E, initiated by ADVN or ABAP. The 
extrapolated c,t/t,t ratios exhibit a significant drop in 
value. Two examples illustrate this result. 
In one example, the combination of ADVN initiation 
and inhibition by Trolox was used for controlled peroxida- 
tion of the monomer methyl inoleate solubilized in satu- 
rated (non-oxidizing) dimyristoylphosphatidylcholine 
(DMPC) MLV liposomes. Results, plotted in Fig. 8, show 
that the extrapolated c,t/t,t ratio drops to 1.3. A second 
experiment (not shown), employing the combination of 
ADVN initiation and Trolox inhibition during inhibited 
peroxidation of DLPC, gave an extrapolated c,t/t,t ratio of 
3.5. These results indicate that Trolox is not an efficient 
antioxidant, when compared to that of vitamin E, when 
peroxidation is initiated in the lipid phase. 
The sites of oxygen attack at the linoleate chain, 9 
versus 13, is also of interest because of the polar property 
of the intermediate peroxyl radicals formed (see Discus- 
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Fig. 8. Cis, trans to trans, trans (c,t/t,t) linoleate hydroperoxides (O) and 
9/13 ratios (v ) ,  from peroxidation of methyl linoleate in DMPC, 
initiated by ADVN, inhibited by Trolox. The end of the induction period 
is shown by ~. The rate of chain initiation = 8.37.10 -8 M s -] . Molar 
quantities are Trolox, 3.43.10 -8 mol; methyl inoleate, 6.06.10 -5 mol; 
DMPC, 9.66.10 -5 1; ADVN, 3.35.10 -6 mol. 
sion). There does not appear to be a significant preference 
for the site of oxidation. In the Figs. 5-8, the 9/13 ratios 
are approximately unity (usually 0.9-1.0) throughout the 
course of the inhibition period. 
4. Discussion 
Trolox is a remarkable antioxidant which is known to 
trap two membrane lipid peroxyl radicals per molecule of 
Trolox [35] (e.g., its stoichiometric factor is 2) despite the 
fact that it appears to reside mainly in the aqueous phase. 
The current sensitive partitioning data using [14C]Trolox 
are in general agreement with the earlier results on parti- 
tioning using other methods (e.g., spectroscopic), where up 
to 30% partitioning into egg lecithin ULV was found [35]. 
The fact that Trolox partitions more readily into unilamel- 
lar egg lecithin vesicles (at least 40%) than in multi- 
lamellar vesicles (25%) indicates that it does not readily 
distribute itself uniformly into all layers of MLV. This is 
significant when evaluating its quantitative behaviour as an 
antioxidant in such heterogeneous systems. 
Further insight into the dynamics of the antioxidant 
action of Trolox is obtained by following the partitioning 
of total ¿4C-radioactivity (Trolox and oxidation products) 
between the aqueous and lipid phase during the controlled 
peroxidation of DLPC liposomes. Now the membrane 
bound total ~4C rapidly approaches 40%. This result indi- 
cates that an equilibrium is readily established between 
Trolox (aqueous) and Trolox (lipid) on this time scale. It 
was important to demonstrate hat the consumption of total 
Trolox and the end of the inhibition period do in fact 
coincide, within experimental error. This is found to be the 
case as illustrated in the example shown in Fig. 4. This 
finding supports the preliminary report [33] on the use of 
Trolox for quantitative studies of autoxidation kinetics in 
model membranes and demonstrates that it is a very 
convenient method to measure the rate of free radical 
initiation during controlled peroxidation of model mem- 
branes by azo initiators. 
Product studies of the hydroperoxides formed during 
the inhibition period provide some additional insight into 
the antioxidant action of Trolox compared to that of 
lipid-soluble vitamin E. The high c,t/t,t ratio of derived 
hydroperoxides during initiation by the water-soluble 
ABAP shows that Trolox is an efficient inhibitor of per- 
oxidation of membrane lipid linoleate (at least as efficient 
as vitamin E) and that Trolox is not merely trapping 
initiator peroxyl radicals. On the other hand, the lower 
relative hydrogen atom donating ability of Trolox when 
peroxidation is initiated in the lipid phase of MLV (e.g., 
Fig. 8) may be due to a lack of uniform distribution of the 
inhibitor Trolox between all layers of the MLV system. 
The initiator is presumably uniformly distributed by the 
co-evaporation method. Thus, under this circumstance~ 
some peroxidation would continue uninhibited in the inner 
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layers and this allows for build-up of the thermodynamic 
trans, trans isomers resulting in lower c,t/t,t ratios. 
Peroxyl radicals are known to be highly polarized 
[45,46] and attempts have been made to account for the 
kinetic results of autoxidation i  bilayers in terms of the 
dynamics of such polar peroxyls when they are formed 
initially in the nonpolar lipid layers of membranes [35,47]. 
It is postulated that such polar peroxyl radicals would 
diffuse rapidly from the nonpolar lipid phase, where they 
are initially formed, towards the polar aqueous surface 
where they would terminate or be trapped (in our experi- 
ments) by a water-soluble inhibitor (e.g., Trolox). Such a 
diffusion-trapping mechanism would account for the very 
effective action of Trolox when initiation occurs with the 
water-soluble initiator, ABAP. Such a mechanism might 
also be reflected in changes in the substitution pattern of 
the 9- and 13-hydroperoxides formed with the combination 
of ABAP and Trolox, especially for the Trolox-inhibited 
peroxidation of methyl inoleate in DMPC. In this case the 
linoleate is not bonded to the PC and derived peroxyl 
radicals might diffuse more freely. However, in this as in 
all experiments, the 9/13 ratios are in the range 0.9 to 1.0. 
A similar observation was made earlier when oz-tocopherol 
was the inhibitor [42]. Equivalent yields of the 9- and 
13-1inoleate hydroperoxides under all conditions in our 
inhibition experiments ~, including those inhibited by 
Trolox, may be due to two related phenomena. First, if 
diffusion of peroxyls to the aqueous phase occurs in 
membranes, it may be faster than the bimolecular hydro- 
gen transfer from inhibitors so that the two peroxyls at 
positions 9- and 13- are trapped at the same rate by Trolox. 
Second, the trapping of the two peroxyls initially formed at 
positions 9- and 13- may be equally facile by Trolox 
because it is distributed in both phases. 
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